Effect of early administration of coagulation factor XIII on fistula after pancreatic surgery: the FIPS randomized controlled trial
- 56 Downloads
The administration of exogenous factor XIII (FXIII) is reportedly effective for fistula closure in patients with a low plasma FXIII level. This study was performed to analyze the effect of early administration of exogenous FXIII on postoperative pancreatic fistula (POPF).
A single-center randomized controlled, open-label, parallel group, superiority trial was conducted from October 2015 to August 2016 in Japan. Patients with POPF and a plasma FXIII level of ≤ 70% on postoperative day 7 were randomly assigned to an early replacement (ER) group or control group in a 1:1 ratio by an independent coordinator using a computer-generated random number table. The ER group received FXIII concentrate the day after randomization, and the control group received no FXIII concentrate within 2 weeks. The primary endpoint was the duration of drain placement from randomization (DDPR).
Fifty patients were randomized (ER group, 24; control group, 26), and all were analyzed with an intention-to-treat approach. There was no significant difference in the DDPR between the two groups (18 vs. 16 days; hazard ratio, 1.45; 95% confidence interval, 0.813–2.583). No serious harm was reported in either group.
Early administration of exogenous FXIII does not facilitate the healing of POPF.
University Hospital Medical Information Network (UMIN) Center (UMIN000019480, http://www.umin.ac.jp).
KeywordsPostoperative pancreatic fistula Coagulation factor XIII Early cure RCT
Data access and responsibility
The principal investigator, Yoshinori Takeda, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
The contribution of each author was as follows. YT—conception and design of the study, acquisition of data, and drafting of the manuscript. YM—conception and design of the work and drafting and critical revision of the manuscript. NI—analysis and interpretation of data and critical revision of the manuscript. SH—analysis and interpretation of data AND critical revision of the manuscript. BH—analysis and interpretation of data and critical revision of the manuscript. YI—analysis and interpretation of data and critical revision of the manuscript. TI—analysis and interpretation of data and critical revision of the manuscript. HI—analysis and interpretation of data and critical revision of the manuscript. YT—analysis and interpretation of data and critical revision of the manuscript. AS—analysis and interpretation of data and critical revision of the manuscript.
Compliance with ethical standards
This research involved human participants. Informed consent was obtained from all individual participants included in the present study.
All procedures performed in this study involving human participants were in accordance with the ethical standards of the institution and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare that they have no conflicts of interest.
- 7.Seitz R, Duckert F, Lopaciuk S, Muszbek L, Rodeghiero F, Seligsohn U (1996) ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Study Group. Semin Thromb Hemost 22(5):415–418. https://doi.org/10.1055/s-2007-999040 CrossRefGoogle Scholar
- 12.Saigusa S, Yamamura T, Tanaka K, Ohi M, Kawamoto A, Kobayashi M, Inoue Y, Kusunoki M (2011, 2011) Efficacy of administration of coagulation factor XIII with definitive surgery for multiple intractable enterocutaneous fistulae in a patient with decreased factor XIII activity. BMJ Case Rep. https://doi.org/10.1136/bcr.09.2010.3342
- 13.Nishino H, Kojima K, Oshima H, Nakagawa K, Fumura M, Kikuchi N (2013) [A case of pancreatic and duodenal fistula after total gastrectomy successfully treated with coagulation factor XIII]. Gan to kagaku ryoho. Cancer Chemother 40(12):2304–2306Google Scholar
- 15.Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG, Conlon K, Del Chiaro M, Falconi M, Fernandez-Cruz L, Fernandez-Del Castillo C, Fingerhut A, Friess H, Gouma DJ, Hackert T, Izbicki J, Lillemoe KD, Neoptolemos JP, Olah A, Schulick R, Shrikhande SV, Takada T, Takaori K, Traverso W, Vollmer CR, Wolfgang CL, Yeo CJ, Salvia R, Buchler M, International Study Group on Pancreatic S (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 161(3):584–591. https://doi.org/10.1016/j.surg.2016.11.014 CrossRefGoogle Scholar
- 16.Mishima Y, Nagao F, Ishibiki K, Matsuda M, Nakamura N (1984) Factor XIII in the treatment of postoperative refractory wound-healing disorders. Results of a controlled study. Chirurg 55(12):803–808Google Scholar
- 19.Sato T, Saiura A, Inoue Y, Takahashi Y, Arita J, Takemura N (2016) Distal pancreatectomy with en bloc resection of the celiac axis with preservation or reconstruction of the left gastric artery in patients with pancreatic body cancer. World J Surg 40(9):2245–2253. https://doi.org/10.1007/s00268-016-3550-x CrossRefGoogle Scholar
- 21.Valle JW, Palmer D, Jackson R, Cox T, Neoptolemos JP, Ghaneh P, Rawcliffe CL, Bassi C, Stocken DD, Cunningham D, O'Reilly D, Goldstein D, Robinson BA, Karapetis C, Scarfe A, Lacaine F, Sand J, Izbicki JR, Mayerle J, Dervenis C, Olah A, Butturini G, Lind PA, Middleton MR, Anthoney A, Sumpter K, Carter R, Buchler MW (2014) Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J Clin Oncol Off J Am Soc Clin Oncol 32(6):504–512. https://doi.org/10.1200/jco.2013.50.7657 CrossRefGoogle Scholar
- 22.Shrikhande SV, Sivasanker M, Vollmer CM, Friess H, Besselink MG, Fingerhut A, Yeo CJ, Fernandez-delCastillo C, Dervenis C, Halloran C, Gouma DJ, Radenkovic D, Asbun HJ, Neoptolemos JP, Izbicki JR, Lillemoe KD, Conlon KC, Fernandez-Cruz L, Montorsi M, Bockhorn M, Adham M, Charnley R, Carter R, Hackert T, Hartwig W, Miao Y, Sarr M, Bassi C, Buchler MW (2017) Pancreatic anastomosis after pancreatoduodenectomy: a position statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 161(5):1221–1234. https://doi.org/10.1016/j.surg.2016.11.021 CrossRefGoogle Scholar
- 26.Saeki H, Masuda T, Okada S, Ando K, Sugiyama M, Yoshinaga K, Endo K, Sadanaga N, Emi Y, Kakeji Y, Morita M, Yamashita N, Maehara Y (2010) Impact of perioperative peripheral blood values on postoperative complications after esophageal surgery. Surg Today 40(7):626–631. https://doi.org/10.1007/s00595-009-4135-1 CrossRefGoogle Scholar